Aurinia Pharmaceuticals Inc. (AUPH) Net margin 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) net profit margin by fiscal year — reported net income divided by reported revenue.
101.5%FY2025 · since FY2018: -11464.1% → 101.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 101.5% | +99.0 pp |
| FY2024 | 2.4% | +46.9 pp |
| FY2023 | -44.5% | +36.3 pp |
| FY2022 | -80.7% | +316.1 pp |
| FY2021 | -396.8% | -191.9 pp |
| FY2020 | -204.9% | +27589.1 pp |
| FY2019 | -27794.0% | -16329.9 pp |
| FY2018 | -11464.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →